MAPPING OF METASTASIS SUPPRESSOR GENE(S) FOR RAT PROSTATE-CANCER ON THE SHORT ARM OF HUMAN-CHROMOSOME-8 BY IRRADIATED MICROCELL-MEDIATED CHROMOSOME TRANSFER
N. Nihei et al., MAPPING OF METASTASIS SUPPRESSOR GENE(S) FOR RAT PROSTATE-CANCER ON THE SHORT ARM OF HUMAN-CHROMOSOME-8 BY IRRADIATED MICROCELL-MEDIATED CHROMOSOME TRANSFER, Genes, chromosomes & cancer, 17(4), 1996, pp. 260-268
Our previous studies demonstrated that human chromosome 8 contains met
astasis suppressor gene(s) for rat prostate cancer, However, it is sti
ll unknown which portion of human chromosome 8 is associated with supp
ression of metastatic ability, because all of the clones in which meta
static ability is suppressed contain at least one copy of intact human
chromosome 8, In the present study, we used the irradiated microcell-
mediated chromosome transfer technique to enrich for specific chromoso
mal arm deletions of selected chromosomes. The resultant series of hum
an chromosomes 8 with a variety of chromosomal deletions was introduce
d into highly metastatic Dunning rat prostate cancer cells, All of the
resultant microcell hybrids showed reduced metastatic ability. To obt
ain a smaller size of human chromosome 8 and to locate further the reg
ion of metastasis suppressor gene(s), the most reduced size of human c
hromosome 8 that was generated with the initial irradiated chromosome
transfer was retransferred into the Dunning cancer cells without irrad
iation. The resultant microcell hybrids were analyzed to determine whi
ch portion of human chromosome 8 suppressed the metastatic ability of
the recipient cells, This analysis demonstrates that the portion of hu
man chromosome 8 containing metastasis suppressor gene(s) for rat pros
tate cancer cells lies on human chromosome segment 8p21-p12, where fre
quent allelic losses have been detected in allelotype analyses of huma
n prostate cancer. This suggests that one of the metastasis suppressor
genes for rat prostate cancer on human chromosome 8 may also play an
important role in the progression of human prostate cancer. (C) 1996 W
iley-Liss, Inc.